Previously, screening for cardiovascular disease (CVD) focused on hyperlipidemia, obesity, and hypertension. However, approximately one half of AMIs occur in healthy men and women with normal or only slightly elevated plasma lipids. With new insights into cardiac disease and the ACS, novel biomarkers such as inflammatory markers, hormones, and other biomolecules indicating myocardial stress are required. Some new screening markers are in use today and many more are in study and evaluation for future use.
New screening markers for CVD and ACS are:
- Highly Sensitive C-Reactive Protein (hs-CRP)
- Homocysteine
- Ischemial Modified Albumin (IMA)
- Myeloperoxidase (MPO)